<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>279(12)</volume><submitter>De Luca P</submitter><funding>Università degli Studi di Salerno</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To analyze the demographic data, surgical and adjuvant treatment data and the survival outcomes in adult patients affected by acinic cell carcinoma of the parotid gland (AciCC).&lt;h4>Methods&lt;/h4>A retrospective multicenter analysis of patients treated for AciCC of the parotid gland from 2000 to 2021 was performed. Exclusion criteria were pediatric (0-18 years) patients, the absence of follow-up and patients with secondary metastatic disease to the parotid gland. Multivariable logistic regression was used to determine factors associated with survival.&lt;h4>Results&lt;/h4>The study included 81 adult patients with AciCC of the parotid gland. The median age was 46.3 years (SD 15.81, range 19-84 years), with a gender female prevalence (F = 48, M = 33). The mean follow-up was 77.7 mo</pubmed_abstract><journal>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</journal><pagination>5821-5829</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9649501</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Acinic cell carcinoma of the parotid gland: Timeo Danaos et dona ferentes? A multicenter retrospective analysis focusing on survival outcome.</pubmed_title><pmcid>PMC9649501</pmcid><pubmed_authors>Iemma M</pubmed_authors><pubmed_authors>Vigili MG</pubmed_authors><pubmed_authors>Pellini R</pubmed_authors><pubmed_authors>Ricciardiello F</pubmed_authors><pubmed_authors>Dallan I</pubmed_authors><pubmed_authors>Togo G</pubmed_authors><pubmed_authors>Salzano FA</pubmed_authors><pubmed_authors>Colangeli R</pubmed_authors><pubmed_authors>De Luca P</pubmed_authors><pubmed_authors>Radici M</pubmed_authors><pubmed_authors>Salzano G</pubmed_authors><pubmed_authors>Ionna F</pubmed_authors><pubmed_authors>de Campora L</pubmed_authors><pubmed_authors>Petruzzi G</pubmed_authors><pubmed_authors>de Campora E</pubmed_authors><pubmed_authors>Cassano M</pubmed_authors><pubmed_authors>Esposito E</pubmed_authors><pubmed_authors>Atturo F</pubmed_authors><pubmed_authors>Presutti L</pubmed_authors><pubmed_authors>Molinari G</pubmed_authors><pubmed_authors>Condorelli P</pubmed_authors><pubmed_authors>Raso F</pubmed_authors><pubmed_authors>Camaioni A</pubmed_authors><pubmed_authors>D'Ecclesia A</pubmed_authors><pubmed_authors>Lo Manto A</pubmed_authors><pubmed_authors>Cintoli G</pubmed_authors><pubmed_authors>Fermi M</pubmed_authors><pubmed_authors>Abeshi A</pubmed_authors><pubmed_authors>Tassone D</pubmed_authors><pubmed_authors>Di Stadio A</pubmed_authors><pubmed_authors>Magaldi L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acinic cell carcinoma of the parotid gland: Timeo Danaos et dona ferentes? A multicenter retrospective analysis focusing on survival outcome.</name><description>&lt;h4>Objectives&lt;/h4>To analyze the demographic data, surgical and adjuvant treatment data and the survival outcomes in adult patients affected by acinic cell carcinoma of the parotid gland (AciCC).&lt;h4>Methods&lt;/h4>A retrospective multicenter analysis of patients treated for AciCC of the parotid gland from 2000 to 2021 was performed. Exclusion criteria were pediatric (0-18 years) patients, the absence of follow-up and patients with secondary metastatic disease to the parotid gland. Multivariable logistic regression was used to determine factors associated with survival.&lt;h4>Results&lt;/h4>The study included 81 adult patients with AciCC of the parotid gland. The median age was 46.3 years (SD 15.81, range 19-84 years), with a gender female prevalence (F = 48, M = 33). The mean follow-up was 77.7 mo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-19T10:40:24.208Z</modification><creation>2025-04-19T10:40:24.208Z</creation></dates><accession>S-EPMC9649501</accession><cross_references><pubmed>35678874</pubmed><doi>10.1007/s00405-022-07481-w</doi></cross_references></HashMap>